rejevity bpc-157 BPC-157 — Research Peptide |

Or sign in without password Please enter your username or email address

Theoretical Tumor Growth Risk: BPC-157's angiogenic activity raises a theoretical concern that new blood vessel formation at tumor sites from existing or undetected malignancies accelerates tumor growth

Typically, the dose is increased every month until a long-term maintenance dose is reached, but the timeframe can be customized to your needs

Dietary Supplement

Post-COVID-19 syndrome and the potential benefits of exercise

MET has been shown to influence the regulation of pro-apoptotic and anti-apoptotic factors to promote cell survival or proliferation through activating many signalling pathways including the Mitogen-Activated Protein Kinase (MAPK) cascade such as ERK1/2, Jun amino-terminal kinases (JNKs), p38, PI3K-AKT and STAT3 [41, 42]